Response to Office Action

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1957 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

Response to Office Action

To the Commissioner for Trademarks:

Application serial no. 88648848 CARESENS N(Standard Characters, see http://uspto.report/TM/88648848/mark.png) has been amended as follows:

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following:

Current:
Class 005 for reagents for medical use, diagnostic test reagents for medical purposes, medicinal diagnostic reagents for testing and analyzing body fluids, diagnostic reagents for measuring blood ketone levels for medicinal use, diagnostic reagents for immunization for medicinal use, diagnostic agents for medical use, enzyme preparations for medical purposes, in vitro diagnostic reagents for medical purposes, test strips for testing blood glucose levels, medical diagnostic test strips for blood analysis, cotton for medical purposes, control solutions for medical purposes, control solutions for blood ketone monitoring devices for medical purposes, test strips for the detection of blood glucose
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 04/05/2018 and first used in commerce at least as early as 04/05/2018 , and is now in use in such commerce.


Proposed:

Tracked Text Description: reagents for medical use, diagnostic test reagents for medical purposes, medicinal diagnostic reagents for testing and analyzing body fluids, diagnostic reagents for measuring blood ketone levels for medicinal use, diagnostic reagents for immunization for medicinal use, diagnostic agents for medical use, enzyme preparations for medical purposes, in vitro diagnostic reagents for medical purposes, test strips for testing blood glucose levels, medical diagnostic test strips for blood analysis, cotton for medical purposes, control solutions for medical purposes, control solutions for blood ketone monitoring devices for medical purposes, test strips for the detection of blood glucose; Reagents for medical use, diagnostic test reagents for medical purposes, medicinal diagnostic reagents for testing and analyzing body fluids, diagnostic reagents for measuring blood ketone levels for medicinal use, diagnostic reagents for immunization for medicinal use, diagnostic agents for medical use, enzyme preparations for medical purposes, in vitro diagnostic reagents for medical purposes, test strips for testing blood glucose levels, medical diagnostic test strips for blood analysis, cotton for medical purposes, test strips for the detection of blood glucoseClass 005 for Reagents for medical use, diagnostic test reagents for medical purposes, medicinal diagnostic reagents for testing and analyzing body fluids, diagnostic reagents for measuring blood ketone levels for medicinal use, diagnostic reagents for immunization for medicinal use, diagnostic agents for medical use, enzyme preparations for medical purposes, in vitro diagnostic reagents for medical purposes, test strips for testing blood glucose levels, medical diagnostic test strips for blood analysis, cotton for medical purposes, test strips for the detection of blood glucose
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 04/05/2018 and first used in commerce at least as early as 04/05/2018 , and is now in use in such commerce.
Applicant proposes to amend the following:

Current:
Class 010 for blood testing apparatus for medical use, analyzers for analyzing and measuring the level of glucose in the blood for medical use, blood glucose meters, devices for measuring blood sugar levels, medical diagnostic apparatus and instruments for testing blood sugar levels, medical apparatus for testing the level of glucose in the blood, in vitro diagnostic devices for medical purposes, blood analysis apparatus for medical diagnostic purposes, continuous blood glucose monitor, medical apparatus and instruments, blood gas monitoring systems, medical instruments for monitoring blood coagulation, electrodes for medical use, glycated hemoglobin measuring, apparatus for medical purposes, sensor apparatus for medical use in diagnosis, sensor for continuous blood glucose monitor for monitoring blood glucose for medical purposes, apparatus for taking blood, needles for medical purposes, mobile monitoring scanners for medical purposes
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 04/05/2018 and first used in commerce at least as early as 04/05/2018 , and is now in use in such commerce.


Proposed:

Tracked Text Description: blood testing apparatus for medical use, analyzers for analyzing and measuring the level of glucose in the blood for medical use, blood glucose meters, devices for measuring blood sugar levels, medical diagnostic apparatus and instruments for testing blood sugar levels, medical apparatus for testing the level of glucose in the blood, in vitro diagnostic devices for medical purposes, blood analysis apparatus for medical diagnostic purposes, continuous blood glucose monitor, medical apparatus and instruments, blood gas monitoring systems, medical instruments for monitoring blood coagulation, electrodes for medical use, glycated hemoglobin measuring, apparatus for medical purposes, sensor apparatus for medical use in diagnosis, sensor for continuous blood glucose monitor for monitoring blood glucose for medical purposes, apparatus for taking blood, needles for medical purposes, mobile monitoring scanners for medical purposes; Blood testing apparatus for medical use, analyzers for analyzing and measuring the level of glucose in the blood for medical use, blood glucose meters, devices for measuring blood sugar levels, medical diagnostic apparatus and instruments for testing blood sugar levels, medical apparatus for testing the level of glucose in the blood; in vitro diagnostic devices for medical purposes, namely, for blood analysis; blood analysis apparatus for medical diagnostic purposes; monitors, medical apparatus and instruments all for continuous blood glucose monitoring; blood gas monitoring systems comprised of monitors, medical instruments for monitoring blood coagulation, electrodes for medical use; glycated hemoglobin measuring apparatus for medical purposes; sensor apparatus for medical use in diagnosis, namely, blood glucose sensors; sensor for continuous blood glucose monitor for monitoring blood glucose for medical purposes, apparatus for taking blood, needles for medical purposes; mobile monitoring scanners for medical purposes, namely, ultrasound imaging scannersClass 010 for Blood testing apparatus for medical use, analyzers for analyzing and measuring the level of glucose in the blood for medical use, blood glucose meters, devices for measuring blood sugar levels, medical diagnostic apparatus and instruments for testing blood sugar levels, medical apparatus for testing the level of glucose in the blood; in vitro diagnostic devices for medical purposes, namely, for blood analysis; blood analysis apparatus for medical diagnostic purposes; monitors, medical apparatus and instruments all for continuous blood glucose monitoring; blood gas monitoring systems comprised of monitors, medical instruments for monitoring blood coagulation, electrodes for medical use; glycated hemoglobin measuring apparatus for medical purposes; sensor apparatus for medical use in diagnosis, namely, blood glucose sensors; sensor for continuous blood glucose monitor for monitoring blood glucose for medical purposes, apparatus for taking blood, needles for medical purposes; mobile monitoring scanners for medical purposes, namely, ultrasound imaging scanners
Filing Basis: Section 1(a), Use in Commerce: The applicant is using the mark in commerce, or the applicant's related company or licensee is using the mark in commerce, on or in connection with the identified goods and/or services. 15 U.S.C. Section 1051(a), as amended. The mark was first used at least as early as 04/05/2018 and first used in commerce at least as early as 04/05/2018 , and is now in use in such commerce.
OWNER AND/OR ENTITY INFORMATION
Applicant proposes to amend the following:
Current: I-SENS, INC., a corporation of Korea, South, having an address of
      43, Banpo-daero 28-gil, Seocho-gu
      Seoul, 137-873
      Korea, South

Proposed: I-SENS, INC., a corporation of Korea, South, having an address of
      43, Banpo-daero 28-gil, Seocho-gu
      Seoul, 137-873
      Korea, South
      Email Address: XXXX
Correspondence Information (current):
      YOUNG SEOK KOO
      PRIMARY EMAIL FOR CORRESPONDENCE: ykoo@la.ladas.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): LA_MAIL@la.ladas.com; achinaryan@la.ladas.com

The docket/reference number is 5T19719777.
Correspondence Information (proposed):
      Young Seok KOO
      PRIMARY EMAIL FOR CORRESPONDENCE: ykoo@la.ladas.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): LA_MAIL@la.ladas.com; achinaryan@la.ladas.com

The docket/reference number is 5T19719777.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

SIGNATURE(S)
Response Signature
Signature: /Young Seok Koo/     Date: 07/20/2020
Signatory's Name: Young Seok Koo
Signatory's Position: Attorney of record, New York Bar member

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    YOUNG SEOK KOO
   LADAS & PARRY, LLP
   
   4525 WILSHIRE BLVD. SUITE 240
   LOS ANGELES, California 90010
Mailing Address:    Young Seok KOO
   LADAS & PARRY, LLP
   4525 WILSHIRE BLVD. SUITE 240
   LOS ANGELES, California 90010
        
Serial Number: 88648848
Internet Transmission Date: Mon Jul 20 21:47:13 ET 2020
TEAS Stamp: USPTO/ROA-XXXX:XXXX:XXXX:XXXX:XXXX:XXXX:
XXXX:XXXX-20200720214713392708-88648848-
7402436d88a2816cea9e2acb8de227627ff73d49
4cf496f957a146313587448-N/A-N/A-20200720
213418674217